REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial

Abstract Background Pain is common in the first 2 days after major craniotomy. Inadequate analgesia may lead to an increased risk of postoperative complications. Most pain following craniotomy arises from the pericranial muscles and soft tissues of the scalp. Scalp nerve blocks with local anesthesia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chunmei Zhao, Zipu Jia, Niti Shrestha, Fang Luo
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/b321b26a79214b8baac5dd2cb7aa7424
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b321b26a79214b8baac5dd2cb7aa7424
record_format dspace
spelling oai:doaj.org-article:b321b26a79214b8baac5dd2cb7aa74242021-11-08T11:02:49ZREDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial10.1186/s13063-021-05747-y1745-6215https://doaj.org/article/b321b26a79214b8baac5dd2cb7aa74242021-11-01T00:00:00Zhttps://doi.org/10.1186/s13063-021-05747-yhttps://doaj.org/toc/1745-6215Abstract Background Pain is common in the first 2 days after major craniotomy. Inadequate analgesia may lead to an increased risk of postoperative complications. Most pain following craniotomy arises from the pericranial muscles and soft tissues of the scalp. Scalp nerve blocks with local anesthesia seem to provide effective, safe, however, transient postoperative analgesia which does not seem to meet the requirements of craniotomy. Currently, peripheral dexamethasone has been observed to significantly prolong the duration of analgesia of nerve blocks (e.g., saphenous nerve block, adductor canal block, thoracic paravertebral block, brachial plexus nerve block). On the contrary, a study reported that perineural dexamethasone did not appear to prolong the analgesic time after supratentorial craniotomy. However, all patients in this study were given 24 mg of oral or intravenous dexamethasone regularly for at least 7 days during the perioperative period, which possibly masked the role of single local low doses of perineural dexamethasone. Therefore, the analgesic effect of single dexamethasone for scalp nerve blocks without the background of perioperative glucocorticoid deserves further clarification. Methods The REDUCE trial is a prospective, single-center, parallel-group randomized controlled trial involving a total of 156 adults scheduled for elective craniotomy with general anesthesia. Patients will be randomly divided among two groups: the control group (n = 78) will receive scalp nerve blocks with 0.5% bupivacaine, plus normal saline with epinephrine at 1:200,000; the DEX4mg group (n = 78) will receive scalp nerve blocks with 0.5% bupivacaine, plus 4 mg dexamethasone with epinephrine at 1:200,000. The primary outcome will be the duration of analgesia, defined as the time between the performance of the block and the first analgesic request. Discussion The REDUCE trial aims to further assess the analgesic effect of single dexamethasone as an adjuvant to scalp nerve blocks for relief of postcraniotomy pain without the background of perioperative glucocorticoid. Trial registration ClinicalTrials.gov NCT04648358 . Registered on November 30, 2020.Chunmei ZhaoZipu JiaNiti ShresthaFang LuoBMCarticlePostoperative painCraniotomyDexamethasoneScalp nerve blocksRandomized controlled trialMedicine (General)R5-920ENTrials, Vol 22, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Postoperative pain
Craniotomy
Dexamethasone
Scalp nerve blocks
Randomized controlled trial
Medicine (General)
R5-920
spellingShingle Postoperative pain
Craniotomy
Dexamethasone
Scalp nerve blocks
Randomized controlled trial
Medicine (General)
R5-920
Chunmei Zhao
Zipu Jia
Niti Shrestha
Fang Luo
REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
description Abstract Background Pain is common in the first 2 days after major craniotomy. Inadequate analgesia may lead to an increased risk of postoperative complications. Most pain following craniotomy arises from the pericranial muscles and soft tissues of the scalp. Scalp nerve blocks with local anesthesia seem to provide effective, safe, however, transient postoperative analgesia which does not seem to meet the requirements of craniotomy. Currently, peripheral dexamethasone has been observed to significantly prolong the duration of analgesia of nerve blocks (e.g., saphenous nerve block, adductor canal block, thoracic paravertebral block, brachial plexus nerve block). On the contrary, a study reported that perineural dexamethasone did not appear to prolong the analgesic time after supratentorial craniotomy. However, all patients in this study were given 24 mg of oral or intravenous dexamethasone regularly for at least 7 days during the perioperative period, which possibly masked the role of single local low doses of perineural dexamethasone. Therefore, the analgesic effect of single dexamethasone for scalp nerve blocks without the background of perioperative glucocorticoid deserves further clarification. Methods The REDUCE trial is a prospective, single-center, parallel-group randomized controlled trial involving a total of 156 adults scheduled for elective craniotomy with general anesthesia. Patients will be randomly divided among two groups: the control group (n = 78) will receive scalp nerve blocks with 0.5% bupivacaine, plus normal saline with epinephrine at 1:200,000; the DEX4mg group (n = 78) will receive scalp nerve blocks with 0.5% bupivacaine, plus 4 mg dexamethasone with epinephrine at 1:200,000. The primary outcome will be the duration of analgesia, defined as the time between the performance of the block and the first analgesic request. Discussion The REDUCE trial aims to further assess the analgesic effect of single dexamethasone as an adjuvant to scalp nerve blocks for relief of postcraniotomy pain without the background of perioperative glucocorticoid. Trial registration ClinicalTrials.gov NCT04648358 . Registered on November 30, 2020.
format article
author Chunmei Zhao
Zipu Jia
Niti Shrestha
Fang Luo
author_facet Chunmei Zhao
Zipu Jia
Niti Shrestha
Fang Luo
author_sort Chunmei Zhao
title REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
title_short REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
title_full REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
title_fullStr REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
title_full_unstemmed REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
title_sort reduce trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial
publisher BMC
publishDate 2021
url https://doaj.org/article/b321b26a79214b8baac5dd2cb7aa7424
work_keys_str_mv AT chunmeizhao reducetrialtheeffectsofperineuraldexamethasoneonscalpnerveblocksforreliefofpostcraniotomypainastudyprotocolforarandomizedcontrolledtrial
AT zipujia reducetrialtheeffectsofperineuraldexamethasoneonscalpnerveblocksforreliefofpostcraniotomypainastudyprotocolforarandomizedcontrolledtrial
AT nitishrestha reducetrialtheeffectsofperineuraldexamethasoneonscalpnerveblocksforreliefofpostcraniotomypainastudyprotocolforarandomizedcontrolledtrial
AT fangluo reducetrialtheeffectsofperineuraldexamethasoneonscalpnerveblocksforreliefofpostcraniotomypainastudyprotocolforarandomizedcontrolledtrial
_version_ 1718442461578133504